Chronological Index of BioCentury, Week in Review: Management Tracks

• Oncolytics management update

  Oncolytics Biotech Inc. (TSX:ONC; NASDAQ:ONCY), Calgary, Alberta Business: Cancer Hired: Jeremy Grushcow as general counsel, formerly a partner at Norton Rose LLP

  Published on 2/25/2013

• OncoSec management update

  OncoSec Medical Inc. (OTCBB:ONCS), San Diego, Calif. Business: Cancer Promoted: Veronica Vallejo to CFO from VP and controller

  Published on 2/25/2013

• Onyx management update

  Onyx Pharmaceuticals Inc. (NASDAQ:ONXX), South San Francisco, Calif. Business: Cancer Hired: Pablo Cagnoni as EVP of global R&D and technical operations, effective in March, formerly SVP and global head of clinical …

  Published on 2/25/2013

• ValiRx management update

  ValiRx plc (LSE:VAL), London, U.K. Business: Cancer, Diagnostic Hired: Samuel Ogunsalu as chief commercialization officer

  Published on 2/25/2013

• AcelRx board of directors update

  AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX), Redwood City, Calif. Business: Neurology, Drug delivery Appointed: Adrian Adams, CEO and president of Auxilium Pharmaceuticals Inc., as chairman; he succeeds Thomas Schreck

  Published on 2/18/2013

• Aqua Pharmaceuticals management update

  Aqua Pharmaceuticals LLC, West Chester, Pa. Business: Dermatology Promoted: Ted White to COO from VP of sales

  Published on 2/18/2013

• Aragon Pharmaceuticals management update

  Aragon Pharmaceuticals Inc., San Diego, Calif. Business: Cancer Hired: Paul Cleveland as CFO and EVP of corporate strategy, formerly general partner and COO of Mohr Davidow Ventures

  Published on 2/18/2013

• Bavarian Nordic management update

  Bavarian Nordic A/S (CSE:BAVA), Kvistgaard, Denmark Business: Infectious, Cancer Hired: James Breitmeyer as EVP and division president of Bavarian Nordic's cancer vaccine division, formerly EVP of development and CMO of…

  Published on 2/18/2013

• Elcelyx Therapeutics board of directors update

  Elcelyx Therapeutics Inc., San Diego, Calif. Business: Endocrine/Metabolic Appointed: GSM Fund's Rick Barry

  Published on 2/18/2013

• Evogen management update

  Evogen Inc., Lenexa, Kan. Business: Diagnostic Hired: Robert Dondes as COO; and Hans Kastensmith as president and CEO

  Published on 2/18/2013

• Ironwood management update

  Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), Cambridge, Mass. Business: Gastrointestinal Promoted: Mark Currie to SVP, CSO and president of R&D

  Published on 2/18/2013

• Kolltan management update

  Kolltan Pharmaceuticals Inc., New Haven, Conn. Business: Cancer, Antibodies Hired: Jane Henderson as SVP and CBO, formerly VP of business development at Ista Pharmaceuticals Inc., which Bausch + Lomb Inc. acquired

  Published on 2/18/2013

• Precision Biopsy management update

  Precision Biopsy LLC, Denver, Colo. Business: Diagnostic, Cancer Hired: Amir Tehrani as CEO, formerly president and CEO of Amaranth Medical Inc.

  Published on 2/18/2013

• Prosonix management update

  Prosonix Ltd., Oxford, U.K. Business: Inflammation, Pulmonary, Drug delivery Hired: Cecile Miles as CBO, a newly created role, formerly EU commercial director at Actavis Inc.

  Published on 2/18/2013

• Receptos management update

  Receptos Inc., San Diego, Calif. Business: Autoimmune, Cancer, Inflammation Hired: Graham Cooper as CFO, formerly EVP of finance and CFO of Geron Corp.

  Published on 2/18/2013

• Repros management update

  Repros Therapeutics Inc. (NASDAQ:RPRX), The Woodlands, Texas Business: Genitourinary, Endocrine/Metabolic Hired: Joachim Wernicke as CMO

  Published on 2/18/2013

• Ritter management update

  Ritter Pharmaceuticals Inc., Los Angeles, Calif. Business: Gastrointestinal Hired: Larry Good as CMO

  Published on 2/18/2013

• Shire management update

  Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Business: Neurology, Gastrointestinal, Endocrine/Metabolic Departing: Sylvie Gregoire as president of Shire's Human Genetic Therapies (HGT) business, effective in April;…

  Published on 2/18/2013

• WellPoint Inc. management update

  WellPoint Inc. (NYSE:WLP), Indianapolis, Ind. Business: Other Hired: Joseph Swedish as CEO, effective March 25, formerly president and CEO of Trinity Health Corp.; he succeeds Interim CEO John Cannon, who returns to his…

  Published on 2/18/2013

• Xenon management update

  Xenon Pharmaceuticals Inc., Burnaby, B.C. Business: Pharmacogenetics, Neurology, Endocrine/Metabolic Hired: Gary Bridger as EVP of R&D, formerly CSO of AnorMed Inc., which the Genzyme Corp. unit of Sanofi acquired

  Published on 2/18/2013

• Affymax management update

  Affymax Inc. (NASDAQ:AFFY), Palo Alto, Calif. Business: Hematology Promoted: Christine Conroy to SVP of regulatory affairs and quality assurance from VP of corporate quality and regulatory affairs Retiring: Robert …

  Published on 2/11/2013

• Alliqua management update

  Alliqua Inc. (OTCBB:ALQA), New York, N.Y. Business: Drug delivery, Hepatic, Dermatology Hired: David Johnson, a director, as CEO; he replaces James Sapirstein, who becomes CEO of Alliqua's Alliqua BioMedical Inc. …

  Published on 2/11/2013

• Amorfix management update

  Amorfix Life Sciences Ltd. (TSX:AMF), Mississauga, Ontario Business: Diagnostic, Neurology Hired: Warren Whitehead as CFO, formerly CFO of Arius Research Inc., which Roche acquired; he replaces Janet Clennett, who …

  Published on 2/11/2013

• Anthera management update

  Anthera Pharmaceuticals Inc. (NASDAQ:ANTH), Hayward, Calif. Business: Autoimmune, Cardiovascular Departing: Georgina Kilfoil as SVP of product development, effective Feb. 15

  Published on 2/11/2013

• Aqua Pharmaceuticals management update

  Aqua Pharmaceuticals LLC, West Chester, Pa. Business: Dermatology Retiring: Jay Gooding as CEO, effective in March, while remaining a director; he will be replaced by Craig Ballaron

  Published on 2/11/2013